Savvas Petanidis

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Decision Making

Radiofrequency Ablation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Theodora Katopodi, Savvas Petanidis, Eirini Grigoriadou, Doxakis Anestakis, Charalampos Charalampidis, Ioanna P Chatziprodromidou, George Floros, Panagiotis Eskitzis, Pavlos Zarogoulidis, Charilaos Koulouris, Christina Sevva, Konstantinos Papadopoulos, Panagiota Roulia, Stylianos Mantalobas, Marios Dagher, Vasileios Alexandros Karakousis, Nikolaos Varsamis, Konstantinos Vlassopoulos, Vasiliki Theodorou, Chrysi Maria Mystakidou, Nikolaos Iason Katsios, Konstantinos Farmakis, Christoforos Kosmidis
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy. Pharmaceutics 16 (4) (2024)
Theodora Katopodi, Savvas Petanidis, Eirini Grigoriadou, Doxakis Anestakis, Charalampos Charalampidis, Ioanna P Chatziprodromidou, George Floros, Panagiotis Eskitzis, Pavlos Zarogoulidis, Charilaos Koulouris, Christina Sevva, Konstantinos Papadopoulos, Panagiota Roulia, Stylianos Mantalobas, Marios Dagher, Vasileios Alexandros Karakousis, Nikolaos Varsamis, Konstantinos Vlassopoulos, Vasiliki Theodorou, Chrysi Maria Mystakidou, Nikolaos Iason Katsios, Konstantinos Farmakis, Christoforos Kosmidis
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy. Pharmaceutics 16 (4) (2024)
Theodora Katopodi, Savvas Petanidis, George Floros, Konstantinos Porpodis, Christoforos Kosmidis
Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing. Cells 13 (11) (2024)
Theodora Katopodi, Savvas Petanidis, George Floros, Konstantinos Porpodis, Christoforos Kosmidis
Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing. Cells 13 (11) (2024)
Theodora Katopodi, Savvas Petanidis, George Floros, Konstantinos Porpodis, Christoforos Kosmidis
Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing. Cells 13 (11) (2024)
Theodora Katopodi, Savvas Petanidis, Doxakis Anestakis, Charalampos Charalampidis, Ioanna P Chatziprodromidou, George Floros, Panagiotis Eskitzis, Pavlos Zarogoulidis, Charilaos Koulouris, Christina Sevva, Konstantinos Papadopoulos, Marios Dagher, Nikolaos Varsamis, Vasiliki Theodorou, Chrysi Maria Mystakidou, Nikolaos Iason Katsios, Konstantinos Farmakis, Christoforos Kosmidis
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery. Pharmaceutics 15 (10) (2023)
Theodora Katopodi, Savvas Petanidis, Charalampos Charalampidis, Ioanna P Chatziprodromidou, Panagiotis Eskitzis, Drosos Tsavlis, Pavlos Zarogoulidis, Christoforos Kosmidis, Dimitris Matthaios, Konstantinos Porpodis
Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance. Cells 11 (20) (2022)
Kalliopi Domvri, Savvas Petanidis, Doxakis Anestakis, Konstantinos Porpodis, Chong Bai, Paul Zarogoulidis, Lutz Freitag, Wolfgang Hohenforst-Schmidt, Theodora Katopodi
Dual photothermal MDSCs-targeted immunotherapy inhibits lung immunosuppressive metastasis by enhancing T-cell recruitment. Nanoscale 12 (13) (2021)